AtriCure Swings to Profit in Q2, Raises Full-Year Profitability Outlook
ATRC sits 37% above its 52-week low of $25.36.
Summary
AtriCure reported Q2 2026 revenue of $153.6 million (+12.8% YoY) and net income of $9.0 million, a sharp turnaround from a loss last year. Full-year adjusted EBITDA guidance was raised to $85–$89 million.
Key Events · Earnings and Guidance · ATRC
-
Q2 Revenue Growth of 12.8%
Worldwide revenue reached $153.6 million, driven by 13.6% U.S. growth. Pain management and appendage management were key contributors.
-
Profitability Inflection
Net income of $9.0 million ($0.18 per share) compared to a net loss of $6.2 million in Q2 2025. Adjusted EBITDA rose 78% to $27.3 million.
-
Raised Full-Year Guidance
Management now expects full-year 2026 adjusted EBITDA of $85–$89 million, up from prior implied guidance, and revenue of $602–$610 million.
-
Strong Cash Generation
The company generated $21.6 million in cash during the quarter, ending with $167.8 million in cash and equivalents.
Analysis · ATRC · Industrial Applications And Services
A sharp swing to profitability defined AtriCure's second quarter, as the company turned a prior-year net loss into a $9.0 million profit on the back of 12.8% revenue growth. Adjusted EBITDA surged 78% to $27.3 million, and cash generation reached $21.6 million. Reflecting confidence in sustained margin expansion, management raised full-year adjusted EBITDA guidance to $85–$89 million. The results mark a clear inflection point for the medical device company, driven by strength in pain management and appendage management product lines.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ATRC was trading at $34.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $25.36 to $43.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.